Criteria typically include: [2] Age 18+ with obesity No history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (personal or family) Diagnosed severe sleep apnea (excluding central or complex apnea) Sleep study within past 3 years documenting AHI score (apnea-hypopnea index, measuring sleep apnea severity) Currently following a diet and exercise program Tried preferred alternatives or have documented allergies/contraindications If you suspect you have OSA (snoring, daytime fatigue, witnessed breathing pauses), ask your Kaiser PCP for a sleep study referral
Some may have a fear of intimacy, or they might have anxiety or depression
El Mously S, Abdel Ghaffar H, Magdy R, Hamza S, Mansour M
Patients interested in understanding the scientific background of emerging muscle-related peptide research
As more individuals face health risks associated with excess weight, the demand for GLP-1 receptor agonist, proven to reduce weight, improve glycemic control and lower cardiometabolic risk, is expected to rise substantially, thereby driving the growth of the GLP-1 receptor agonist market
